.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Healthtrust
Medtronic
QuintilesIMS
UBS
Harvard Business School
Teva
McKesson
Cerilliant
Colorcon

Generated: September 26, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203981

« Back to Dashboard
NDA 203981 describes ADAPALENE, which is a drug marketed by Actavis Mid Atlantic, Glenmark Generics, Taro, Fougera Pharms, Pliva Hrvatska Doo, Call Inc, and Tolmar, and is included in nine NDAs. It is available from eleven suppliers. Additional details are available on the ADAPALENE profile page.

The generic ingredient in ADAPALENE is adapalene; benzoyl peroxide. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for NDA: 203981

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Dermatological Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 203981

Ingredient-typeRetinoids

Suppliers and Packaging for NDA: 203981

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADAPALENE
adapalene
SOLUTION;TOPICAL 203981 ANDA CALL INC (d.b.a Rochester Pharmaceuticals) 49908-117 49908-117-60 1 BOTTLE, GLASS in 1 CARTON (49908-117-60) > 60 mL in 1 BOTTLE, GLASS

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;TOPICALStrength0.1%
Approval Date:Sep 23, 2016TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

UBS
Dow
Federal Trade Commission
US Army
US Department of Justice
Harvard Business School
Daiichi Sankyo
Baxter
Medtronic
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot